3Di-Sciascio G, Patti G, Pasceri V,et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention : results of the ARMYDA-RECAPTURE( Atorvastadn for Reduction of Myocardial Damage During Angioplasty ) Randomized Trial[J]. J Am Coll Cardiol,2009,54(6) : 558-565.
4Garcia Rodr-guez LA, Barreales Tolosa L. Risk of upper gastrointesti- nal complications among users of traditional NSAIDs and COXIBs in the general population [ J ]. Gastroenterology,2007,132 ( 2 ) :498-506.
5Rhee E J, Lee WY, Kim SY, et al. Relationship of serum osteoprote- gerin levels with coronary artery disease severity ,left ventrlcular hyper- trophy and C-reactive protein [ J ]. Chn Sci ( Lond ), 2005,108 ( 3 ) : 237 -243.
6Sandberg WJ, Yadestad A, Oie E, et al. Enhanced T cell expression of RANK ligand in acute coronary syndrome : possible role in plaque destabilization [ J ]. Arterioscler Thromb Vasc Biol, 2006,26 ( 4 ) : 857-863.
7Morony S, Tintut Y, Zhang Z, et al. Osteopmtegerin inhibits vascular calcification without affecting atherosclerosis in ldlr mice[J]. Circulation,2008,117(3) :411- 420.
8陈灏珠,钟南山,陆再英.内科学[M].第8版.北京:人民卫生出版社,2013:3.
9Relou IA, Hackeng CM, Akkerman JW, et al. low-density lipo- protein and its effect on human blood platelets [ J ]. Cell Mol life Sci ,2003,60 (5) :961-971.
10Nesar Hossein V, Yosef Nejad K, Abdollahian F. Short-term therapy with high dose atorvastatin in patients with coronary artery disease can reduce inflammatory process [ J ]. Acta Med Iran,2010,48 (4) :218-221.
